share_log

Evaluating Silk Road Medical: Insights From 6 Financial Analysts

Evaluating Silk Road Medical: Insights From 6 Financial Analysts

评估丝路医疗:来自6位金融分析师的见解
Benzinga ·  05/01 13:00
Ratings for Silk Road Medical (NASDAQ:SILK) were provided by 6 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
在过去三个月中,有6位分析师提供了丝路医疗(纳斯达克股票代码:SILK)的评级,显示了看涨和看跌的观点。
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
下表简要介绍了他们最近的收视率,展示了过去30天中不断变化的情绪,并将其与前几个月进行了比较。
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $20.83, with a high estimate of $24.00 and a low estimate of $18.00. Surpassing the previous average price target of $15.60, the current average has increased by 33.53%.
分析师对12个月目标股价的评估提供了更多见解,显示平均目标价为20.83美元,最高估计为24.00美元,低估值为18.00美元。超过了之前的平均目标股价15.60美元,目前的平均价格上涨了33.53%。
Decoding Analyst Ratings: A Detailed Look
解码分析师评级:详细介绍
The standing of Silk Road Medical among...
通过对近期分析...
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发